Literature DB >> 32616921

High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.

Kohei Hosokawa1, Hirohito Yamazaki2, Mikoto Tanabe1, Tatsuya Imi1, Naomi Sugimori1, Shinji Nakao3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32616921     DOI： 10.1038/s41375-020-0950-6

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

Review 1.  Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.

Authors:  Yan Man; Zhixiang Lu; Xiangmei Yao; Yuemin Gong; Tonghua Yang; Yajie Wang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 2.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

3.  Developments in the production of platelets from stem cells (Review).

Authors:  Jie Yang; Jianfeng Luan; Yanfei Shen; Baoan Chen
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

4.  Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report.

Authors:  Rebecca Baur; Regina Jitschin; Soraya Kharboutli; Andrej Stoll; Simon Völkl; Maike Büttner-Herold; Daniela Schmidt; Wolf Rösler; Andreas Mackensen; Dimitrios Mougiakakos
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.